April 29, 2020 07:17 AM EDT
Deals
Cell/Gene Tx

Hav­ing sold its cor­po­rate self, Toca­gen auc­tions off sci­en­tif­ic plat­form to San Diego biotech

Jason Mast

Editor

With the der­mati­tis spe­cial­ists at Forte Bio­sciences now in­hab­it­ing Toca­gen’s cor­po­rate skele­ton, a small San Diego biotech has won rights to its sci­en­tif­ic plat­form …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times